课题基金 / 基金详情

HUMAN MONOCLONAL ANTIBODIES

HUMAN MONOCLONAL ANTIBODIES
人单克隆抗体
批准号:
3231756
负责人:
Diane J Nugent
金额:
$17.06万
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-01-01 至 1995-01-31

项目摘要

项目成果

Diane J Nugent的其他基金

相似基金

相关文献

中文摘要
翻译
我们的目标是定义自身免疫反应的性质 特发性血小板减少性紫癜(ITP)患者。具体来说,我们 将从Epstein Barr中分离出人源性抗血小板单抗 从ITP患者分离的病毒转化的B淋巴细胞 鉴定血小板自身抗原。这种方法允许我们检查 产生的自身抗体的谱和这些表位的性质 作为膜靶抗原的GPIIb-IIIa或GPIB。我们的长期计划 目标是为ITP的病因提供新的见解,并开发更安全的 慢性ITP患者的治疗方案。 我们明年的目标包括: 1)抗GPIB和抗GPIB-IIIa特异性自身抗体细胞的制备 来自一系列已知含有血清学定义的患者的基因 他们的血浆中有独特型抗血小板抗体。 2.)对这些细胞系的可变区进行检测以 确定a.)存在的多态程度和b.)联谊会 这些特定的体细胞突变具有抗GPIB反应活性。 3.)人源性抗GPIB-IIIa或Ib-IX单抗用于治疗 在这些分子上绘制免疫原区的地图。 4)继续使用这些抗独特型抗体进行检测和 慢性阻塞性肺疾病患者血清中GPIB特异性抗体的特征 并确定哪些患者的治疗更具侵略性 可能需要一些养生法。
英文摘要
Our objective is to define the nature of the autoimmune response in patients with idiopathic thrombocytopenic purpura (ITP). Specifically, we will isolate human monoclonal antiplatelet antibodies from Epstein Barr Virus transformed B lymphocytes, isolated from patients with ITP, to identify platelet autoantigens. This approach allows us t examine the spectrum of autoantibodies produced and the nature of those epitopes of GPIIb-IIIa or GPIb which serve as membrane target antigens. Our long term goal is to provide new insights into the etiology of ITP and develop safer treatment regimens for those patients with chronic ITP. Our goals in the next year include: 1.) production of anti-GPIb and anti-GPIb-IIIa specific autoantibody cell lines from a series of patients known to contain serologically defined idiotypic antiplatelet antibodies in their plasma. 2.) examination of the variable gene region of these cell lines to determine the a.)degree of polymorphism present and b.) the association of these specific somatic mutations with anti-GPIb reactivity. 3.) utilization of human monoclonal anti-GPIb-IIIa or Ib-IX antibodies to map immunogenic regions on these molecules. 4,) Continued use of these anti-idiotypic antibodies for the detection and characterization of GPIb-specific antibodies in the sera of patients with ITP and to identify those patients in whom more aggressive therapeutic regimens may be indicated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preventing Bleeding Disorder Complications thru Hemophilia Tx Ctrs in Region IX
Preventing Bleeding Disorder Complications thru Hemophilia Tx Ctrs in Region IX
Preventing Bleeding Disorder Complications thru Hemophilia Tx Ctrs in Region IX
Preventing Bleeding Disorder Complications thru Hemophilia Tx Ctrs in Region IX
海外基金